These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28101929)

  • 21. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.
    Yeo W; Mo FK; Suen JJ; Ho WM; Chan SL; Lau W; Koh J; Yeung WK; Kwan WH; Lee KK; Mok TS; Poon AN; Lam KC; Hui EK; Zee B
    Breast Cancer Res Treat; 2009 Feb; 113(3):529-35. PubMed ID: 18327706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of oral side effects of chemotherapy and its relationship with periodontal risk: a cross sectional study.
    García-Chías B; Figuero E; Castelo-Fernández B; Cebrián-Carretero JL; Cerero-Lapiedra R
    Support Care Cancer; 2019 Sep; 27(9):3479-3490. PubMed ID: 30675665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Taste alterations during neo/adjuvant chemotherapy and subsequent follow-up in breast cancer patients: a prospective single-center clinical study.
    Pedersini R; Zamparini M; Bosio S; di Mauro P; Turla A; Monteverdi S; Zanini A; Amoroso V; Vassalli L; Cosentini D; Grisanti S; Simoncini EL; Berruti A
    Support Care Cancer; 2022 Aug; 30(8):6955-6961. PubMed ID: 35538327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the risk factors associated with high-dose chemotherapy-induced dysgeusia in patients undergoing autologous hematopoietic stem cell transplantation: possible usefulness of cryotherapy in dysgeusia prevention.
    Okada N; Hanafusa T; Abe S; Sato C; Nakamura T; Teraoka K; Abe M; Kawazoe K; Ishizawa K
    Support Care Cancer; 2016 Sep; 24(9):3979-85. PubMed ID: 27129837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measuring the maintenance of daily life activities using the functional living index-emesis (FLIE) in patients receiving moderately emetogenic chemotherapy.
    Decker GM; DeMeyer ES; Kisko DL
    J Support Oncol; 2006 Jan; 4(1):35-41, 52. PubMed ID: 16444851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful treatment of crizotinib-induced dysgeusia by switching to alectinib in ALK-positive non-small cell lung cancer.
    Koizumi T; Fukushima T; Tatai T; Kobayashi T; Sekiguchi N; Sakamoto A; Sasaki S
    Lung Cancer; 2015 Apr; 88(1):112-3. PubMed ID: 25678258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials.
    Di Maio M; Gallo C; Leighl NB; Piccirillo MC; Daniele G; Nuzzo F; Gridelli C; Gebbia V; Ciardiello F; De Placido S; Ceribelli A; Favaretto AG; de Matteis A; Feld R; Butts C; Bryce J; Signoriello S; Morabito A; Rocco G; Perrone F
    J Clin Oncol; 2015 Mar; 33(8):910-5. PubMed ID: 25624439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of education in managing side effects in women receiving chemotherapy for treatment of breast cancer.
    Williams SA; Schreier AM
    Oncol Nurs Forum; 2004; 31(1):E16-23. PubMed ID: 14722602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stated preferences of patients with cancer for health-related quality-of-life (HRQOL) domains during treatment.
    Osoba D; Hsu MA; Copley-Merriman C; Coombs J; Johnson FR; Hauber B; Manjunath R; Pyles A
    Qual Life Res; 2006 Mar; 15(2):273-83. PubMed ID: 16468082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Willingness to pay to prevent chemotherapy induced nausea and vomiting among patients with breast, lung, or colorectal cancer.
    Miller PJ; Balu S; Buchner D; Walker MS; Stepanski EJ; Schwartzberg LS
    J Med Econ; 2013 Oct; 16(10):1179-89. PubMed ID: 23919632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nausea, vomiting and quality of life of patients with cancer undergoing antineoplastic treatment: an evaluation by pharmacists.
    de Souza CM; Visacri MB; Ferrari GB; Tuan BT; Costa AP; Barbosa CR; Lima CS; Mazzola PG; Moriel P
    Int J Pharm Pract; 2015 Oct; 23(5):357-60. PubMed ID: 25572714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Doctors' and Breast Cancer Patients' Perceptions of Docetaxel, Epirubicin, and Cyclophosphamide (TEC) Toxicity.
    Bayo J; Prieto B; Rivera F
    Breast J; 2016 May; 22(3):293-302. PubMed ID: 26864346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Taste and smell perception and quality of life during and after systemic therapy for breast cancer.
    de Vries YC; Boesveldt S; Kelfkens CS; Posthuma EE; van den Berg MMGA; de Kruif JTCM; Haringhuizen A; Sommeijer DW; Buist N; Grosfeld S; de Graaf C; van Laarhoven HWM; Kampman E; Winkels RM
    Breast Cancer Res Treat; 2018 Jul; 170(1):27-34. PubMed ID: 29476290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of chemotherapy-related nausea on patients' nutritional status, psychological distress and quality of life.
    Farrell C; Brearley SG; Pilling M; Molassiotis A
    Support Care Cancer; 2013 Jan; 21(1):59-66. PubMed ID: 22610269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of chemotherapy on the quality of life of lung cancer patients].
    Liu X; Wang Y; Li S; Xin S; Cao J
    Zhongguo Fei Ai Za Zhi; 2013 Dec; 16(12):656-60. PubMed ID: 24345491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Choice of study endpoint significantly impacts the results of breast cancer trials evaluating chemotherapy-induced nausea and vomiting.
    Ng T; Mazzarello S; Wang Z; Hutton B; Dranitsaris G; Vandermeer L; Smith S; Clemons M
    Breast Cancer Res Treat; 2016 Jan; 155(2):337-44. PubMed ID: 26732944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Taste changes experienced by patients receiving chemotherapy.
    Wickham RS; Rehwaldt M; Kefer C; Shott S; Abbas K; Glynn-Tucker E; Potter C; Blendowski C
    Oncol Nurs Forum; 1999 May; 26(4):697-706. PubMed ID: 10337648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The assessment of health-related quality of life and related factors in Chinese elderly patients undergoing chemotherapy for advanced cancer: a cross-sectional study.
    Li Q; Lin Y; Qiu Y; Gao B; Xu Y
    Eur J Oncol Nurs; 2014 Aug; 18(4):425-35. PubMed ID: 24721179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occurrence of Dysgeusia in Patients Being Treated for Cancer.
    Di Meglio J; Dinu M; Doni L; Rossi G; Giorgione R; Colombini B; Antonuzzo L; Sofi F
    Nutr Cancer; 2022; 74(8):2868-2874. PubMed ID: 35196919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of concord grape juice on chemotherapy-induced nausea and vomiting: results of a pilot study.
    Ingersoll GL; Wasilewski A; Haller M; Pandya K; Bennett J; He H; Hoffmire C; Berry C
    Oncol Nurs Forum; 2010 Mar; 37(2):213-21. PubMed ID: 20189927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.